Stock Research for ADHD

ADHD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ADHD Stock Chart & Research Data

The ADHD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADHD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ADHD Due diligence Resources & Stock Charts

The ADHD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ADHD Detailed Price Forecast - CNN Money CNN View ADHD Detailed Summary - Google Finance
Yahoo View ADHD Detailed Summary - Yahoo! Finance Zacks View ADHD Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ADHD Trends & Analysis - Trade-Ideas Barrons View ADHD Major Holders - Barrons
NASDAQ View ADHD Call Transcripts - NASDAQ Seeking View ADHD Breaking News & Analysis - Seeking Alpha
Spotlight View ADHD Annual Report - CompanySpotlight.com OTC Report View ADHD OTC Short Report - OTCShortReport.com
TradeKing View ADHD Fundamentals - TradeKing Charts View ADHD SEC Filings - Bar Chart
WSJ View Historical Prices for ADHD - The WSJ Morningstar View Performance/Total Return for ADHD - Morningstar
MarketWatch View the Analyst Estimates for ADHD - MarketWatch CNBC View the Earnings History for ADHD - CNBC
StockMarketWatch View the ADHD Earnings - StockMarketWatch MacroAxis View ADHD Buy or Sell Recommendations - MacroAxis
Bullish View the ADHD Bullish Patterns - American Bulls Short Pains View ADHD Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ADHD Stock Mentions - StockTwits PennyStocks View ADHD Stock Mentions - PennyStockTweets
Twitter View ADHD Stock Mentions - Twitter Invest Hub View ADHD Investment Forum News - Investor Hub
Yahoo View ADHD Stock Mentions - Yahoo! Message Board Seeking Alpha View ADHD Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for ADHD - SECform4.com Insider Cow View Insider Transactions for ADHD - Insider Cow
CNBC View ADHD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ADHD - OTC Markets
Yahoo View Insider Transactions for ADHD - Yahoo! Finance NASDAQ View Institutional Holdings for ADHD - NASDAQ


Stock Charts

FinViz View ADHD Stock Insight & Charts - FinViz.com StockCharts View ADHD Investment Charts - StockCharts.com
BarChart View ADHD Stock Overview & Charts - BarChart Trading View View ADHD User Generated Charts - Trading View


Latest Financial News for ADHD

Alcobra reports 3Q loss
Posted on Thursday November 09, 2017

On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 9 cents. The company's shares closed at $1.35. A year ago, they were trading at $1.91. _____ This story was generated by Automated ...


Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
Posted on Tuesday October 31, 2017

SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into a research collaboration and worldwide license agreement to develop self-amplifying RNA-based vaccines and therapeutics in both human and animal health. The collaboration will bring together Arcturus's LUNAR™ lipid-mediated delivery platform with Synthetic Genomics' RNA replicon platform to potentially enable more efficacious and lower cost vaccines and therapeutics.


Today's Research Reports on Stocks to Watch: Alcobra and Imprimis Pharmaceuticals
Posted on Friday October 20, 2017

NEW YORK, NY / ACCESSWIRE / October 20, 2017 / Alcobra headed higher on Thursday after the company's wholly-owned subsidiary Arcturus entered into a research collaboration and worldwide license agreement ...


Alcobra Ltd (ADHD) Stock Fires Up To The Roof; Here’s Why
Posted on Thursday October 19, 2017

Alcobra Ltd (NASDAQ:ADHD) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 40% upturn. Alcobra's wholly-owned subsidiary, Arcturus, announced that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals - a subsidiary of Johnson & Johnson. According to the agreement, the two companies will work together to develop and commercialize nucleic acid-based drug products for the treatment of Hepatitis B, using Arcturus’ UNA Oligomer chemistry and LUNAR™ lipid-mediated delivery platform.


Enter a stock symbol to view the stock details.